التفاصيل البيبلوغرافية
| العنوان: |
Nano-based drug delivery systems in hepatocellular carcinoma. |
| المؤلفون: |
Abtahi, Maryam Sadat, Fotouhi, Alireza, Rezaei, Niloufar, Akalin, Hilal, Ozkul, Yusuf, Hossein-Khannazer, Nikoo, Vosough, Massoud |
| المصدر: |
Journal of Drug Targeting; Nov2024, Vol. 32 Issue 9, p977-995, 19p |
| مصطلحات موضوعية: |
DRUG delivery systems, PROGNOSIS, HEPATOCELLULAR carcinoma, THERAPEUTICS, CANCER cells |
| مستخلص: |
The high recurrence rate of hepatocellular carcinoma (HCC) and poor prognosis after medical treatment reflects the necessity to improve the current chemotherapy protocols, particularly drug delivery methods. Development of targeted and efficient drug delivery systems (DDSs), in all active, passive and stimuli-responsive forms for selective delivery of therapeutic drugs to the tumour site has been extended to improve efficacy and reduce the severe side effects. Recent advances in nanotechnology offer promising breakthroughs in the diagnosis, treatment and monitoring of cancer cells. In this review, the specific design of DDSs based on the different nano-particles and their surface engineering is discussed. In addition, the innovative clinical studies in which nano-based DDS was used in the treatment of HCC were highlighted. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Drug Targeting is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |